Background: The epidemiology and prevalence of the Human T-cell leukemia virus type-1
(HTLV-1) infection represent a recommended priority by global health agencies. An in-depth …

Background Human T‐lymphotropic virus Type 1 (HTLV‐1) is a retrovirus that is endemic in
some regions of the world. It is known to cause several diseases like adult T‐cell leukemia …

Background Blood transfusion is associated with potential risks of transfusion-transmitted
infections (TTIs). Different strategies are needed to monitor blood safety and screen the …

Abstract Background HTLV-1-associated myelopathy (HAM/TSP) is a progressive
neurodegenerative inflammatory condition of HTLV-1 infection. Viral-host interactions are a …

Prevention and treatment of the Human T-cell leukemia virus, type 1 (HTLV-1) which was
discovered nearly 40 years ago, still remain challenging. The reported high prevalence of …

Human T-lymphotropic virus type 1 (HTLV-1) is estimated to affect 5 to 10 million people
globally and can cause severe and potentially fatal disease, including adult T-cell …

Objectives Human lymphotropic virus type 1 (HTLV-1) is the cause of two major diseases,
ATLL and HAM/TSP in a percentage of carriers. Despite progress in understanding the …

En el presente estudio describimos y caracterizamos la distribución geográfica de los casos
positivos confirmados a HTLV-1 y 2 de pacientes peruanos con diagnóstico presuntivo entre …

Human T-lymphotropic viruses (HTLV) are Deltaretroviruses that infect millions of individuals
worldwide via the same transmission routes as HIV. With the aim of exposing the possible re …

Human T‐cell leukemia virus type I (HTLV‐1) infection is endemic in Japan, particularly
clustered in the southwestern district, Kyushu‐Okinawa, which consists of eight prefectures …